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The circadian clock and the hypoxia-signaling pathway are regulated by an integrated interplay of pos-
itive and negative feedback limbs that incorporate energy homeostasis and carcinogenesis. We show
that the negative circadian regulator CRY1 is also a negative regulator of hypoxia-inducible factor
(HIF). Mechanistically, CRY1 interacts with the basic-helix-loop-helix domain of HIF-1a via its tail re-
gion. Subsequently, CRY1 reduces HIF-1a half-life and binding of HIFs to target gene promoters.
This appeared to be CRY1 specific because genetic disruption of CRY1, but not CRY2, affected the
hypoxia response. Furthermore, CRY1 deficiency could induce cellular HIF levels, proliferation, and
migration, which could be reversed by CRISPR/Cas9- or short hairpin RNA-mediated HIF knockout.
Altogether, our study provides a mechanistic explanation for genetic association studies linking a
disruption of the circadian clock with hypoxia-associated processes such as carcinogenesis.1Faculty of Biochemistry and
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A number of epidemiological studies showed that disturbances of the circadian rhythm strongly correlate
with carcinogenesis and tumor progression in humans (for review see Fu and Lee, 2003; Filipski and Levi,
2009; Sahar and Sassone-Corsi, 2009; Rana and Mahmood, 2010). Accordingly, the International Agency
for Research on Cancer classified shift work as a group 2A carcinogenic factor (Straif et al., 2007).
The circadian rhythm inmammals is maintained by an integrated network of the central (neural or brain) and
peripheral (tissue-specific) clocks. The central clock is located in the suprachiasmatic nucleus of the brain,
receives light cues to keep in phase with the light-dark cycle, and synchronizes the peripheral clocks in
various tissues through a variety of electrical, endocrine, and metabolic signaling pathways (Albrecht,
2012; Richards and Gumz, 2012). At the genetic level, both the central and the peripheral clocks are regu-
lated by an interplay of positive and negative feedback loops involving the same set of clock genes (Yagita
et al., 2001). Thereby, the bHLH-PAS transcription factors CLOCK (circadian locomotor output cycles kaput)
and BMAL1 (brain-muscle Arnt-like protein 1) represent the major components of the core clock’s positive
limb. They induce, among others, the expression of the proteins PER (period 1,2) and CRY (cryptochrome
1,2), which constitute the major arm of the negative limb. The induced PER and CRY proteins then form a
complex with each other as well as with modulator proteins such as CK1ε, CKII, or FBXL3 and act as repres-
sors of CLOCK/BMAL heterodimers. Subsequently, they inhibit their own expression as well as those of
other CLOCK/BMAL-regulated output genes (Griffin et al., 1999; Kume et al., 1999; Yoo et al., 2005;
Sato et al., 2006). The core loop is interconnected to several other feedback loops, including those of
REV-ERBs or PPARa/RORs, which repress or activate BMAL1 expression, respectively (Albrecht, 2012; Ko
and Takahashi, 2006; Asher and Schibler, 2011). Overall, the continuous interplay between the core
CLOCK/BMAL1 positive limb and the PER/CRY negative limb in concert with post-translational modifica-
tions and interconnected loops results in the oscillation of gene expression in a circadian manner.
Several recent studies have linked clock function with the cell cycle and reported that clock components,
such as PER1, PER2, BMAL1, and CRY1/2 decrease cell proliferation or improve the action of anti-cancer
drugs in different cancer cell lines. Moreover, certain types of human cancer show an altered expression
of circadian clock genes (reviewed in Shostak, 2017).
In addition to disturbances of the circadian clock, most, if not all, solid tumors display hypoxic areas. Hyp-
oxia has been shown to be the major driver of tumor angiogenesis and a critical determinant for284 iScience 13, 284–304, March 29, 2019 ª 2019 The Author(s).
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proliferation, cell growth, and apoptosis (Semenza, 2017; Masson and Ratcliffe, 2014; Kaelin and Ratcliffe,
2008). Mechanistically, a group of the bHLH-PAS family transcription factors called hypoxia-inducible tran-
scription factors, among which hypoxia-inducible factor (HIF)-1a is the best characterized, mediate the
transcriptional adaptation to hypoxia. Thereby, HIF-1a together with its binding partner HIF-1b (also known
as aryl hydrocarbon receptor nuclear translocator, ARNT) binds to hypoxia-response elements (HREs)
within the promoters of numerous hypoxia-responsive genes (Semenza, 2017, Masson and Ratcliffe,
2014; Kaelin and Ratcliffe, 2008).
The disruption of the circadian rhythm in patients with cancer and the appearance of hypoxia in tumors rai-
ses the question whether and how the deregulation of the circadian clock system has an impact on the hyp-
oxia response. Several findings suggested a cross talk between the circadian clock and the hypoxia
signaling pathway (Hogenesch et al., 1998; Chilov et al., 2001; Eckle et al., 2012), but the mechanisms
behind are not completely understood and have just started to emerge. Recent reports have shown that
the modulation of oxygen levels can reset the circadian clock at the positive limb in a HIF-1a-dependent
manner (Adamovich et al., 2017) and that HIF-1a and BMAL1 engage in a synergistic cross talk (Wu
et al., 2017), which adapts anaerobic metabolism in skeletal muscle (Peek et al., 2017). Although these find-
ings favor the view that this cross talk is bidirectional and would eventually also involve the negative arm of
the circadian key players, their participation, in particular that of CRY proteins, remains unknown. In the cur-
rent study we broaden this view by showing that CRY1, but not CRY2, acts as a repressor of HIFs. This occurs
via a specific protein-protein interaction that reduces the binding of HIFs at the HREs of target gene pro-
moters and by altering HIF half-life. Disruption of the CRY1-HIF cross talk at the cellular level shows that
CRY1 and HIF-1a have an opposite action on cell growth.
Overall, our study identifies a new level of control that links defects in the circadian clock system with
hypoxia signaling and carcinogenesis.RESULTS
Hypoxia Affects the Circadian Rhythm In Vivo
To study the possible interplay between the circadian clock and hypoxia we measured the circadian
behavior of mice under normoxia (21% O2) and hypoxia (17% O2) at 12 h + 12 h light/dark (LD) cycles
and at constant darkness (dark/dark; DD). When mice were kept under both normoxia and hypoxia at
LD they showed circadian periodicity (Figures 1A and 1B). Intriguingly, we observed that mice at DD
lost their circadian rhythm (Figures 1A and 1B) and expressed HIF target genes when exposed to hypoxia
(Figure 1C). Together, these data indicate that hypoxia is able to modulate the circadian rhythm.The Cell-Autonomous Circadian Oscillation in NIH3T3 Cells Is Affected by HIF-1a or HIF-2a
As the hypoxia-mediated loss of the circadian rhythm in mice at DD stems from systemic and cell-autono-
mous oscillator effects, we next tested to what extent hypoxia affects the cell-autonomous clock. To do this,
we first verified the effect of chronic hypoxia (3% O2 for 32 h) in synchronized Per2:Luc-transfected fibro-
blasts, which possess a cell-autonomous and self-sustained circadian clock (Yagita et al., 2001; Balsalobre
et al., 1998). We found that hypoxia affected the circadian rhythm in two ways, first by reducing the ampli-
tude and second by shortening the period by about 30 min (Figures 2A and 2B). Given that the response to
hypoxia is mainly mediated by an increased abundance of the transcription factors HIF-1a and HIF-2a, we
next investigated how HIF-1a or HIF-2a affect the circadian clock. To do this, we first cotransfected an
expression vector for a hypoxia-mimicking hydroxylation-resistant HIF-1a variant (P/P/N) (Flu¨gel et al.,
2012) with the circadian rhythm reporter Bmal1:Luc and analyzed circadian rhythmicity. Similar to hypoxia,
overexpression of HIF-1a shortened the circadian period and reduced the amplitude (Figures 2C and 2D).
Overexpression of HIF-2a showed a similar response (Figures S1A and S1B). In contrast to hypoxia and
HIFs, the non-specific prolyl hydroxylase inhibitor dimethyloxalylglycine (DMOG), which is often consid-
ered as a hypoxia mimetic, lengthened the period (Figures S1C and S1D). Together, these data indicate
that HIF-1a and HIF-2a mimic the effect of hypoxia on the circadian clock, whereas the DMOG effects
appear to be HIF independent.The Circadian Oscillation of PAI-1 Is Affected by Hypoxia
The aforementioned observations appear to be important for genes that are responsive to both
hypoxia and the circadian clock. The SERPINE1 gene encoding plasminogen activator inhibitor-1iScience 13, 284–304, March 29, 2019 285
Figure 1. Representative Actograms of Individually Monitored Mice under Normoxia and Hypoxia at Light-Dark
Cycles (LD) and Constant Darkness (DD)
(A) Mice were kept under normoxia (n = 14) and hypoxia (B) (n = 14) at 12-h light/12-h dark cycles (LD) for a week, which was
followed by another week under the same conditions at constant darkness (DD).
(C) Hypoxia-dependent induction of Cited2 and Glut-1 mRNA in liver and kidney of the mice after the DD period. The
respective mRNA levels were assessed by qRT-PCR, and the values indicate fold-change hypoxia versus normoxia. Boxes
represent the interquartile range. Whiskers represent the minimum and maximum observations. *Significant difference
normoxia versus hypoxia.(PAI-1) fulfills these criteria and is well known to be a bona fide hypoxia-responsive and circadian-rhythm-
regulated gene (Dimova et al., 2005; Kietzmann et al., 1999; Maemura et al., 2000; Schoenhard et al.,
2003; Wang et al., 2006; Oishi et al., 2009; Cheng et al., 2011). Therefore we investigated whether the
hypoxia-induced shifts in circadian rhythmicity are transferred to the expression of hypoxia-responsive
target genes and to what extent one or the other response prevails. To examine this, we analyzed
PAI-1 expression on protein and reporter gene level in synchronized cells. We found that hypoxia
enhanced PAI-1 expression and shortened the circadian period of PAI-1 by about 40 min (Figures
3A–3D). Together, these data further substantiate that hypoxia and HIFs can advance the period of
clock-dependent genes, whereas the amplitude is likely also modulated depending on the transcriptional
context.286 iScience 13, 284–304, March 29, 2019
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Figure 2. The Circadian Oscillation in NIH3T3 Cells Is Affected by HIF-1a
(A and B) (A) Representative examples of the bioluminescence oscillations in NIH3T3mPer2:Luc cells precultured under
hypoxia (3% O2) for 32 h. (B) Graphical illustration of the amplitude (y axis) and period length (x axis) upon hypoxia
treatment. Data are mean G SEM. *p < 0.05.
(C) Representative example of the bioluminescence oscillations in NIH3T3 cells cotransfected with an mBmal1:luciferase
reporter construct and either empty vector (black line) or HIF-1a P/P/N (green line).
(D) Graphical illustration of the amplitude (y axis) and period length (x axis) upon overexpression of HIF-1a P/P/N. Data are
mean G SEM. *p < 0.05, ***p < 0.001.CRY1 Interacts with HIF-1a and HIF-2a
Accumulating genetic data indicate that the negative limb of the circadian regulators, in particular CRY1, is
responsible for maintaining the period length or amplitude of the circadian clock and that CRY1 is the most
potent repressor in the clock’s negative limb (Griffin et al., 1999; Kume et al., 1999; Van Der Horst et al.,
1999; Vitaterna et al., 1999; Li et al., 2016; Liu et al., 2007; Khan et al., 2012; Matsuo et al., 2003; Koike
et al., 2012; Langmesser et al., 2008; Ye et al., 2014; Michael et al., 2017). Based on CRY1’s potency and re-
sponsibility for period and amplitude maintenance and the recent reports on the HIF-1a-BMAL1 cross talk
(Wu et al., 2017; Peek et al., 2017) as well as the aforementioned findings that HIFs shortened the period
and affected the amplitude of the circadian clock, we hypothesized that HIFs would interact with CRY1.
To examine this, we performed coimmunoprecipitation analyses with hypoxic mouse embryonic fibroblasts
(MEFs). The assays revealed that CRY1 could be detected when HIF-1awas precipitated from the cells (Fig-
ure 4A). Furthermore, CRY1 could also be detected upon precipitation with HIF-2a antibodies, although the
binding signal was low because of the low abundance of HIF-2a (Figure S2A). Next, we verified these inter-
actions and performed western blot analyses from immunoprecipitates of HEK293 cells expressing Myc-
tagged HIF-1a, V5-tagged HIF-2a, and hemagglutinin (HA)-tagged CRY1. The blots from anti-Myc-tagged
HIF-1a or anti-V5-tagged HIF-2a immunoprecipitations showed the presence of HA-tagged CRY1 when
probed with the HA-tag antibody indicating interaction of HIFa proteins and CRY1 (Figures 4B and S2B).
In addition, HIFa proteins were also able to interact with CRY2 (Figures 4C and S2C). We also employed
a bimolecular fluorescence complementation (BiFC) assay to verify whether these interactions are direct.
The BiFC assay takes advantage from the possibility that a fluorescent protein complex can be formed
through association of two per se non-interacting and non-fluorescent N-terminal (YN) and C-terminal
(YC) fragments of the yellow fluorescent protein (YFP). The complementation of the fluorescent complex
is achieved when YN and YC are brought into proximity owing to a direct interaction of the proteins
fused to the YN and YC fragments (Figure 4D) (Kerppola, 2008). We generated vectors allowing expression
of fusionproteins consisting ofHIF-1aorHIF-2a and theC-terminal part of theYFP (HIF-1a-YCorHIF-2a -YC)
as well as of CRY1 and the N-terminal part of the YFP (CRY1-YN). In addition, constructs for the HIFa partner
ARNT as well as for the CRY1 partner PER1 served as positive controls to indicate HIF-1a -ARNT or CRY1-
PER1 interaction, respectively. The BiFC analyses revealed a strong fluorescent signal when either HIF-
1a-YC (Figures 4E and 4F) or HIF-2a-YC (Figure S2D) and CRY1-YN constructs were applied in the assay.
In addition, a clear fluorescent signal could be observed when HIF-1a-YC was coexpressed with ARNT-
YN or PER1-YC with CRY1-YN as positive controls (Figures 4E, S2D, and S2E). By contrast, when HIF-
1a-YC or HIF-2a -YC was coexpressed with a vector encoding only YN (Figures 4E and 4F) no fluorescence
was detected. Likewise, the coexpression of YC and YNdid not result in the generation of fluorescence, indi-
cating that the separated non-fluorescent fragments did not spontaneously self-assemble (Figures 4E
and 4F). Together, these results indicate that HIF-1a and HIF-2a can interact with CRY1 in living cells.
The Tail Region of CRY-1 Interacts with HIF-1a
To find out which domain within CRY1 interacts with HIF-1a, we expressed Myc-tagged HIF1a along with
different HA-tagged CRY1 protein variants in HEK293 cells (Figure 5A) and analyzed their interaction by
coimmunoprecipitation experiments. Full-length CRY1 interacted with HIF-1a, but this interaction was
lost when CRY1 proteins lacking either the CC and tail region or only the tail region were employed in
the assays (Figure 5B). Thus, these data indicate that the tail region of CRY1 is necessary for the interaction
of CRY1 with HIF-1a.
CRY1 Interacts with the bHLH Domain of HIF-1a
To map the exact HIF-1a domain that interacts with CRY1, we designed several Myc-tagged HIF-1a dele-
tion mutants comprising one or several domains (Figure 6A) and performed coimmunoprecipitation288 iScience 13, 284–304, March 29, 2019
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Figure 3. The Circadian Oscillation of PAI-1 Expression Is Affected by Hypoxia
(A) Representative example of the bioluminescence oscillations in cells stably transfected with a PAI-1 promoter-driven
luciferase construct under normoxia and hypoxia.
(B and C) (B) Graphical illustration of the amplitude (y axis) and period length (x axis) of PAI-1 promoter-driven luciferase
expression under normoxia and hypoxia. Data are mean G SEM. *p < 0.05. (C) Representative western blot analysis of
total cell lysates of synchronized Rat-1 fibroblasts probed with PAI-1 and b-actin antibodies.
(D) Densitometric analysis of the PAI-1 protein levels presented on (C).experiments in HA-CRY1 expressing HEK293 cells. When full-length HIF-1a or its deletion variants were
pulled down with anti-Myc-tag antibodies we found that HA-CRY1 coprecipitated full-length HIF-1a and
all deletion variants except the HIF-1amutant lacking the bHLH domain (Figure 6B). Together, these results
indicate that CRY1 interacts with the bHLH domain of HIF-1a.
CRY1 Inhibits Binding of HIF-1a to Its Target Gene Promoters
As CRY1 interacts with the HIF-1a bHLH domain, which primarily facilitates binding to DNA at target gene
promoters, we next analyzed how CRY1 would affect hypoxia and HIF-dependent gene expression. First,
we performed a series of functional reporter gene assays in HepG2 cells. Upon cotransfection of these
cells with the hypoxia- and HIF-responsive wild-type (WT) human PAI-1 promoter Luc construct
(pGL3-hPAI-806/+19) and an expression vector for CRY1 we found that the hypoxia-mediated increase
in Luc activity was reduced in the presence of CRY1. This effect was mediated via the hypoxia responsive
element (HRE) within the PAI-1 promoter because a construct with a mutated element (pGL3-hPAI-HREm)
did not display this effect on Luc activity (Figure 7A). Vice versa, when we employed MEFs deficient
for either CRY1 (DCRY1) or CRY2 (DCRY2) to measure PAI-1 expression, we found that deficiency of
CRY1, but not CRY2, enhanced PAI-1 levels already under normoxia to almost the same levels as
under hypoxia (Figures S3A and S3C). Reintroduction of CRY1 (Figures S3D and S3E) rescued the
hypoxia-dependent PAI-1 expression indicating that these effects are largely CRY1 specific. In line
with the interaction assays, these rescue effects were dependent on the tail region of CRY1 since
only full-length CRY1, but not CRY1-Dtail, rescued the hypoxia-dependent induction of PAI-1 (Figures
S3D and S3E). Thus, CRY1 appears to function as inhibitor of the hypoxia-dependent PAI-1 gene
expression.
Next, we aimed to substantiate the inhibitory effect of CRY1 for HIF-driven genes and HIFs. To do this, we
used bona fide hypoxia reporters containing either three WT HIF-binding HREs or three mutated HREs in
front of the SV40 promoter and the luciferase gene. We then cotransfected these reporters together with a
CRY1 expression vector or empty control vector into HepG2 cells. Hypoxia induced Luc activity in the con-
trol cells, whereas expression of CRY1 predominantly abolished Luc activity under hypoxia (Figure 7B). This
effect was specific because mutation of critical nucleotides in the HRE (pGL3-HREm) abolished the induc-
tion of Luc activity under hypoxia and the repressive effect of CRY1 (Figure 7B).
As HIFs are dimers consisting of HIF-a and HIF-b (ARNT) subunits, we next investigated whether the CRY1
effect is primarily dependent on each subunit by using the pGL3-HRE Luc construct and the pGL3-HREm
construct together with a CRY1 expression vector and HIF-1a, ARNT, or an empty control vector. We found
that overexpression of CRY1 together with HIF-1a (Figure 7C) or HIF-2a (Figure S4), but not with ARNT,
compromised the ability of HIF-1a to induce HRE-driven Luc activity. Furthermore, cotransfection of the
Luc construct with mutant HREs (pGL3-HREm) along with the respective expression vectors alone or in
combination resulted in Luc activities comparable with the control (Figure 7C). These results, together
with the interaction data, suggest that CRY1 represses HIF-1a function.
To understand whether the inhibitory effect of CRY1 is accompanied by a reduced binding of HIF-1a to
target gene promoters in vivo, we performed chromatin immunoprecipitation (ChIP) assays with WT MEFs
or CRY1-deficient MEFs cultured under normoxia or hypoxia. The ChIP assays were performed with either
unspecific IgG or specific antibodies against mouse HIF-1a or HIF-2a and PCR primers, which allowed
amplification of the HIF-binding PAI-1, VEGF-A, PGK-1, and GLUT-1 promoters (Hu et al., 2007; Tanimoto
et al., 2010; Wu et al., 2016; Schodel et al., 2011). The assays from WT MEFs reveal that both HIF-1a and
HIF-2a preferentially associate with those promoter regions under hypoxia, whereas CRY1-deficient cells
bound HIFs already under normoxia (Figures 7D and S5). Thereby, the normoxic binding of HIF-1a
to each studied promoter in DCRY1 cells was already about 2- to 6-fold higher when compared with
WT MEFs (Figure 7D). This binding was further increased in DCRY1 cells under hypoxia (Figures 7D290 iScience 13, 284–304, March 29, 2019
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Figure 4. CRY1 Interacts with HIF-1a
(A) Coimmunoprecipitation (IP) assays fromwild-typeMEFs cultured under hypoxia in the presence of MG-132. Blots from
anti-HIF-1a IPs were probed with the CRY1 and HIF-1a antibody. The blots shown are representative of three
independent experiments. IB, immunoblotting.
(B and C) Coimmunoprecipitation studies with HEK293 cells, expressing myc-tagged HIF-1a with either (B) HA-tagged
CRY1 or (C) V5-tagged CRY2. Blots from anti-myc-tag IPs were probed with HA-tag or V5-tag antibody. The blots shown
are representative of three independent experiments.
(D and E) BiFC analysis. (D) Schematic representation of expressed proteins employed in BiFC. The sequences encoding
amino acid residues 1–154 (N-terminus [YN]) or 155–238 (C-terminus [YC]) of the yellow fluorescent protein (YFP) were
fused to the 30 ends of the coding regions for HIF-1a, CRY1, or ARNT to generate HIF-1a -YC, CRY1-YN, and ARNT-YN,
respectively. YN and YC are non-fluorescent fragments that do not interact per se with each other. An interaction between
the proteins fused to the YN and YC fragments facilitates their association to form a bimolecular fluorescent complex. (E)
Visualization of the BiFC signal by confocal microscopy. COS-7 cells cotransfected with the expression vectors for HIF-
1a-YC, CRY1-YN, ARNT-YN, and vectors encoding only YN or YC were cultured on glass slides for 24 h. The fluorescence
detection was performed using specific filter sets for YFP and DAPI. Scale bar, 10 mm.
(F) Quantification of the BiFC signal. Cells were transfected as in (E) and quantified by flow cytometry (cf. Transparent
Methods). The cytomegalovirus promoter (CMV) driven-YFP signal was set to 100%. Data are mean G SEM. *p < 0.05.and S5). Together, these results indicate that the presence of CRY1 is able to reduce the binding of HIFs
to the PAI-1, VEGF-A, PGK-1, and GLUT1 promoters.
Absence of CRY1 Increases HIF-1a Half-Life and Induces Its Transcription
Owing to the fact that CRY1 reduces binding of HIF-1a to its target gene promoters and that it is mainly
regulated by post-translational stabilization, we hypothesized that CRY1 may promote HIF-1a degrada-
tion. To analyze this, we measured the HIF-1a protein half-life in the absence and presence of CRY1. Inter-
estingly, we found that DCRY1 cells had higher HIF-1a protein levels thanWTMEFs (Figure 8A). In addition,
the CRY1-deficient cells displayed a prolonged HIF-1a half-life (t1/2: 57 min versus45 min inWT cells) (Fig-
ures 8A and 8B). Furthermore, we examined whether lack of CRY1 would also affect HIF-1a mRNA levels.
Concomitant with the increase in HIF-1a protein levels, we also found that the HIF-1a mRNA levels were
increased by about 2-fold in the CRY1-deficient cells (Figure 8C). In addition, we found that the HIF-2a
mRNA levels were induced by about 10-fold (Figure 8C). Overall, these data indicate that the CRY1-medi-
ated functional repression of HIF-1a DNA binding is also accompanied by reduced transcription and
enhanced HIF-1a protein degradation.
CRY1 and HIFs Have Opposite Roles in Cell Proliferation and Migration
The aforementioned findings suggest a reciprocal regulation of CRY1 and HIF-1a that would be of
importance for cellular growth and survival, in particular during tumor development. To get an overview,
we checked CRY1 and HIF-1a mRNA levels in cancer tissues and the corresponding normal tissues from
the Oncomine (www.oncomine.org) database by applying a threshold of a >10-fold change and p value
of 0.05. The results show that HIF-1a and CRY1 could be oppositely regulated in different tumor entities.
In none of the cases HIF1a and CRY1 were regulated in the same manner, i.e., they were never together
up- or downregulated in the same dataset. The reason(s) why HIF-1a expression was upregulated and
CRY1 expression was not downregulated in the first and sixth microarray datasets and why HIF-1a
expression was not upregulated and CRY1 was downregulated in the second and fifth microarray data-
sets are not known but may reflect the different status of tumor driving mutations, which certainly
confound the regulation (Figure 9). Similarly, we observed CRY1 mRNA induction in HIF-1a-deficient cells
(Figure S7). Given that HIF-1a overexpression is associated with poor survival in several patients with can-
cer (Semenza, 2017), these data together with the higher HIF-1a levels in DCRY1 cells imply that loss of
CRY1 can promote cell growth. Indeed, we found that CRY1-deficient cells showed a higher rate in pro-
liferation, migration, and colony formation than their WT counterparts (Figures 10B–10F and S6). To
assess whether these functional differences are, at least in part, mediated by HIFs we re-investigated
cellular proliferation, motility, and the ability to form colonies in CRY1-deficient cells with either
CRISPR/Cas9-mediated HIF-1a deletion (Figure 10A) or short hairpin RNA (shRNA)-mediated knockdown
of HIF-1a or HIF-2a (Figure S6). In contrast to CRY1 deficiency, lack of HIF-1a reduced proliferation (Fig-
ures 10B and 10C), motility (Figures 10E and 10F) and colony formation (Figure 10D). Interestingly, the
DHIF-1a-DCRY1 cells harboring the combined knockout of HIF-1a and CRY1 displayed growth, motility,
and colony-forming properties resembling those of WT cells (Figures 10B–10E). Similarly, we introduced
scrambled non-effective shRNA or HIF-1a shRNA via retroviral infection into WT and DCRY1 cells. Again,292 iScience 13, 284–304, March 29, 2019
Figure 5. The Tail Domain of CRY1 Is Responsible for Interaction with HIF-1a
(A) Schematic representation of the HA-tagged CRY1 protein variants.
(B) HEK293 cells were transfected with myc-tagged HIF-1a together with HA-tagged full-length CRY1 or its mutants, cell
extracts were prepared and immunoprecipitated with an anti-myc-tag antibody, and precipitates were analyzed by
immunoblot with an anti-HA-tag antibody. As a control the expression levels of the CRY1 protein variants as well as myc-
tagged HIF-1a were verified in whole-cell extracts (Input). IP, immunoprecipitation; IB, immunoblotting.knockdown of HIF-1a or HIF-2a reduced the positive effects on migration and soft agar colony formation
exerted by CRY1 deficiency alone (Figures S6A–S6C).
Thus concomitant deletion of HIFs in DCRY1 cells significantly reduced the stimulating effects exerted by
the absence of CRY1 on cellular growth, colony formation, and cell migration. Together, these data indi-
cate that CRY1 and HIFs have an opposite role on cellular growth.
DISCUSSION
The current study extends recently reported findings on the interplay between the circadian clock and the
hypoxia pathway (Adamovich et al., 2017; Wu et al., 2017; Peek et al., 2017) by providing detailediScience 13, 284–304, March 29, 2019 293
Figure 6. The bHLH Domain of HIF-1a Is Responsible for Interaction with CRY1
(A) Schematic representation of the myc-tagged HIF-1a protein variants.
(B) Coimmunoprecipitation experiments were performed with total proteins from HEK293 cells expressing HA-tagged
CRY1 and myc-tagged full-length HIF-1a or its deletion variants. Anti-myc-tag antibody (IP, immunoprecipitation)-
precipitated proteins were analyzed by immunoblot (IB, immunoblotting) using an anti-HA-tag antibody. As a control the
expression levels of HIF-1a, its deletion variants, as well as the HA-tagged CRY1 proteins were verified in whole-cell
extracts (Input).mechanistic insights indicating how the circadian clock component CRY1 can regulate the hypoxia
response pathway at the level of HIF-1a and HIF-2a. In particular we show that (1) CRY1 directly interacts
with both HIF-1a and HIF-2a, (2) that the interaction of CRY1 with HIFs masks the DNA-binding domain
of HIFs and consequently changes HIF DNA binding and expression of HIF target genes, and (3) that
the CRY1-HIFa interaction is important for cellular growth.294 iScience 13, 284–304, March 29, 2019
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Figure 7. CRY1 Inhibits Binding of HIF-1a to Its Target Gene Promoters
(A and B) Cells were cotransfected with an expression vector for CRY1 along with either (A) the wild-type human PAI-1
promoter Luc construct (pGL3-hPAI-806/+19) or a PAI-1 promoter with a mutated hypoxia-responsive element (HRE)
(pGL3-hPAI-HREm) as well as with (B) Luc reporter gene constructs containing three HIF-binding HREs (pGL3-HRE) or
three mutated HREs (pGL3-HREm) in front of the SV40 promoter and cultured under normoxia (16% O2) and hypoxia (5%
O2) for 24 h. The Luc activity of pGL3-hPAI-806/+19-, pGL3-hPAI-HREm-, pGL3-HRE-, or pGL3-HREm-transfected cells at
16% O2 was set to 1. Values are means G SEM of at least three independent culture experiments, each performed in
duplicate. Statistics, Student’s t test for paired values: *significant difference, p% 0.05.
(C) Cells were cotransfected with pGL3-HRE or pGL3-HREm Luc reporter gene constructs and expression vectors
encoding CRY1, HIF-1a, and ARNT alone or in combination. In each experiment the Luc activity of pGL3-HRE- or pGL3-
HREm-transfected cells at 16% O2 was set to 1. Values are means G SEM of at least three independent culture
experiments, each performed in duplicate. Statistics, Student’s t test for paired values: *significant difference, p% 0.05.
(D) Chromatin immunoprecipitation (ChIP) was performed on cell lysates from formaldehyde cross-linked wild-type or
CRY1-deficient MEFs, cultured under normoxia or hypoxia overnight. DNA fragments were co-precipitated with
antibodies against mouse HIF-1a and amplified by quantitative PCR using primers specific for the mouse PAI-1, VEGF-A,
PGK-1, and GLUT-1 promoters containing the corresponding HRE. Chromatin immunoprecipitation without antibody or
using IgG instead of antibody served as additional specificity controls. Differences in the HIF-1a DNA-binding efficiency
in wild-type and DCRY1 MEFs were calculated by the fold enrichment method relative to the IgG control. Values are
means G SEM of three independent experiments. Statistics, Student’s t test for paired values: *significant difference,
p % 0.05.By broadening the knowledge about CRY1’s involvement inmore than the circadian clock pathway, the cur-
rent study also extends the existing information about the interplay between the circadian clock and the
hypoxia response pathway. Although this cross talk was proposed on the basis of in vitro findings almost
20 years ago (Hogenesch et al., 1998), a functional validation presenting a reciprocal regulation between
the positive clock limb protein BMAL1 and HIF-1a (Peek et al., 2017) was just recently reported while this
study on the negative limb was ongoing.
Our data show that hypoxia can modulate the circadian rhythm in vivo and in vitro. This is in line with find-
ings of a recent study demonstrating that mimicry of circadian physiological oxygen rhythms as occurring in
mouse blood can affect the setting of the clock (Adamovich et al., 2017). In addition, we show that mice
under chronic hypoxia become arrhythmic in total darkness (DD) indicating more severe effects of hypoxia
on the clock in general (Figure 1). Although the reasons are not known yet, these activity data may be the
result of a partial uncoupling of central and peripheral clocks due to disturbed adaptation to chronic hyp-
oxia similar to that seen with restricted feeding (Damiola et al., 2000). This may express as arrhythmicity in
periods coinciding with an increased oxygen consumption (Adamovich et al., 2017) such as the onset of
activity and food ingestion, which in mice normally occur during the dark phase of the daily rhythm.
A complimentary approach with Per2:Luc cells exposed to hypoxia as well as with mBmal1:Luc circadian
reporter cells in which we overexpressed variants of HIF-1a and HIF-2a revealed that hypoxia and HIFs
can not only shorten the period but also decrease the amplitude of the clock (Figures 2 and S1). The ampli-
tude effects of the HIFs seen here are in line with previous studies in which C2C12 and U2OS cells were
treated with DMOG (Wu et al., 2017; Peek et al., 2017). Interestingly, our data appeared to be in contrast
to one study (Wu et al., 2017) wherein overexpression of a degradation-resistant HIF1a (HIF1a-P402A/
P564A) resulted in a lengthening of the period of up to 4 h in U2OS cells. The reasons for the discrepancies
might bemultiple and could be attributable to the different model systems used (U2OS osteosarcoma cells
there versus non-cancer mammalian fibroblasts in our study) or the different way of cell synchronization
(dexamethasone versus forskolin in our study). In addition, the other study used the doxycycline-depen-
dent tetR system to overexpress HIF-1a in U2OS cells. Hence, secondary effects of the doxycycline treat-
ment, which are known to inhibit protein translation in mitochondria and to impair metabolism may lead
to effects that can confound experimental results (Moullan et al., 2015; Chatzispyrou et al., 2015). Nonethe-
less, and despite the differences, both studies underline the important roles of HIF-1a as circadian
modulator.
Although no study, including the present, can yet explain the detailed mechanism by which HIFs and
DMOG affect the period, it is tempting to speculate that this may be mediated by the proposed effects
of HIF on BMAL1 (Peek et al., 2017). Indeed, deletion of HIF-1a resulted in a dramatic reduction in
BMAL1 mRNA levels (Figure S7) in line with another study wherein overexpression of HIF-1a induced it
(Yu et al., 2015). However, HIFs and DMOG appear to act by a different mechanism when seeing the effects296 iScience 13, 284–304, March 29, 2019
Figure 8. CRY1 Deficiency Increases HIF-1a Protein Half-Life and Transcription
(A and B) Measurement of HIF-1a protein half-life in wild-type (WT) and CRY-deficient MEFs (DCRY1). Cells were cultured
for 4 h under hypoxia (5% O2) and after inhibition of protein synthesis with cycloheximide (CHX; 10 mg/mL), endogenous
HIF-1a protein levels were determined by western blot analysis with an antibody against mouse HIF-1a. Autoradiographic
signals were obtained by chemiluminescence and quantified. Values are means G SEM of three independent
experiments. (A) Representative western blots. (B) Quantification of HIF-1a half-life.
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Figure 8. Continued
(C) Quantitative qRT-PCR data. The values in wild-typeMEFs (WT) were set to 1. Values represent meansG SEM of at least
three independent experiments. Statistics, Student’s t test for paired values: *significant difference WT versus
CRY1-deficient cells; p% 0.05.on the period. In the present and previous studies (Wu et al., 2017; Peek et al., 2017) DMOG lengthened the
period (Figure S1), whereas overexpression of HIFs shortened it (Figures 2 and S1). The difference in period
length between DMOG and HIFs is explainable by the rather pleiotropic effects of DMOG, which is a syn-
thetic analog of a-ketoglutarate/2-oxoglutarate. As such, DMOG can act as a pan-inhibitor of a-ketoglu-
tarate/2-oxoglutarate-dependent dioxygenases, a family consisting of about 70 enzymes in humans,
among them the HIF-prolyl 4-hydroxylases (Hirsila et al., 2003; Kietzmann et al., 2017). Consequently, a
number of HIF-independent effects may influence the data achieved upon usage of DMOG. In line are
the results obtained upon knockdown of the a-ketoglutarate/2-oxoglutarate-dependent dioxygenases
FIH-1 and the EglN family, which also resulted in a lengthened period (Wu et al., 2017). To circumvent
the pleiotropic DMOG effects, we used a hydroxylation-resistant HIF-1a variant (PPN) to specify whether
it can mimic the shorter period as seen during chronic hypoxia. Importantly, both HIF-1a and HIF-2a could
resemble the effects of hypoxia on the period (Figures 2 and S1). Thus the difference in period length upon
DMOG usage or EglN and FIH-1 knockdown versus hypoxia or HIF overexpression as seen in this study can
be attributed to non-HIF targets of which several, so far unknown, may be involved in clock regulation (Ivan
and Kaelin, 2017). Together, all these data suggest that the hypoxia-signaling pathway may have different
layers that can affect the circadian period and amplitude.
Intrigued by the HIF effects on the circadian period, and given that CRY proteins represent dominant crit-
ical regulators of the circadian period length in humans andmice (Van Der Horst et al., 1999; Vitaterna et al.,
1999; Li et al., 2016; Hirota et al., 2012; Ode et al., 2017; Oshima et al., 2015; Siepka et al., 2007; Patke et al.,
2017) we hypothesized a connection between HIFs and CRYs. Therefore, we probed whether CRY1 and
CRY2 can interact with HIF-1a and HIF-2a, and indeed our experiments revealed that both CRY proteins
were able to undergo interaction with the two HIF proteins (Figures 4 and S2).
The CRY1 protein contains a conserved photolyase homology region crucially involved in repression of
CLOCK/BMAL1; a C-terminal helix also known as the predicted coiled coil (CC), which interacts with
PER2 and FBXL3 in a mutually exclusive manner; and a C-terminal extension also referred to as the ‘‘tail’’
(Figure 5) (Chaves et al., 2011; Merbitz-Zahradnik and Wolf, 2015). Our mapping experiments showed
that HIF-1a interacts with the CRY1 ‘‘tail’’ region, a part of the protein (Figure 5), which has the ability to
modulate the period length and amplitude of the resulting oscillation (Khan et al., 2012; Xu et al., 2015).
In line, a recent report showed that a dominant CRY1 allele coding for a protein with a deletion of 24 res-
idues in the tail region (Patke et al., 2017) caused lengthening of the circadian period and could be linked to
familial delayed sleep phase disorder. Thus the effects seen under hypoxia on the period length are in
accord with the interaction of HIF-1a with CRY1’s tail region. Furthermore, the tail has been shown to affect
CRY1 translocation, to interact with the BMAL1 transactivation domain possibly in an acetylation-depen-
dent fashion, and to be phosphorylated in a manner that involves regulation by DNA-PK (Xu et al., 2015;
Chaves et al., 2006; Czarna et al., 2011; Hirayama et al., 2007). In addition, the existence of a nuclear local-
ization signal in the CRY1 tail coincides well with the nuclear localization of its interaction with HIFs as seen
in the BiFC assays (Figures 4 and S2). In line, the bHLH domain of HIF-1a, which appears to work as the CRY1
interaction module (Figure 6), also contains a nuclear localization sequence (Kallio et al., 1998). Although
not directly tested in this study, a similar mode of interaction is likely occurring with HIF-2a because
both share an amino acid sequence identity of 85% in the bHLH domain.
As the HIF bHLH domain is primarily involved in DNA binding, it is conceivable that the CRY1 tail could
affect binding of HIFs to target gene promoters causing a repression of their expression. Thereby the
repressive effect of CRY1 may not only depend solely on HIF-1a but also on the promoter context. This
is exemplified with the PAI-1 promoter where CRY1 did not repress its activity under normoxia, whereas
it clearly suppressed its hypoxia-dependent induction. To minimize the influence of the promoter context
and to generalize the findings with respect to HIFs, we then used a bona fide hypoxia reporter containing
three HREs as enhancers in front of the SV40 promoter and the luciferase gene. Indeed, these HRE reporter
gene assays revealed that CRY1 suppressed their activity under normoxia and their hypoxia and HIF-1-
dependent induction. Vice versa, the ChIP experiments from CRY1-deficient cells showed enhanced bind-
ing of HIFs to target gene promoters under both normoxia and hypoxia (Figures 7D and S5). Together,298 iScience 13, 284–304, March 29, 2019
Figure 9. CRY-1 and HIF-1a Show an Opposite Expression Pattern in Human Cancer Cohorts
Analysis of CRY1 and HIF1A mRNA expression profiles in the Oncomine database. Six microarray datasets from different cancer entities were analyzed for
CRY1 and HIF1A mRNA expression and compared with normal tissue using a threshold of >10-fold change and a p value <0.05. Red, upregulated in cancer
versus normal tissue; blue, downregulated in cancer versus normal tissue. Data are presented as log2 median-centered intensity with the median rank of
CRY1 and HIF1AmRNA through each dataset analysis. The rank for a gene is themedian rank for that gene across each of the analyses. The p value for a gene
is its p value for the median-ranked analysis.these effects need to be seen in context with our data showing that absence of CRY1 regulates HIF-1a at
two levels, namely, by increasing its transcription and its stability (Figure 8). Consequently, the net effect is
an increase in HIF-1a binding to its enhancers under both conditions. Overall, these data point to a sup-
pressive role of CRY1, and in particular its tail, in the transcriptional response toward hypoxia at various
stages of the circadian cycle.
The current data are also in agreement with another recent study also showing enhanced HIF-1a levels in
CRY-deficient cells, whereas BMAL1 absence decreased HIF-1a levels (Peek et al., 2017). Similarly, Per2
supported recruitment of HIF-1a to the VEGF promoter (Kobayashi et al., 2017). Together with reports
from mouse liver and cardiac tissue, showing that Hif1a mRNA levels cycled in a circadian manner (Eckle
et al., 2012; Wu et al., 2017) and data showing a rhythmic appearance of nuclear HIF1a in mouse brain
and kidney (Adamovich et al., 2017), the current findings substantiate the existence of a feedback mecha-
nism in which the circadian clock pathway can regulate HIF-1a expression.
Earlier findings from different cancer entities such as chronic myeloid leukemia (Yang et al., 2011), B cell
chronic lymphocytic leukemia (Jantus Lewintre et al., 2009), prostate cancer (Zhu et al., 2009), epithelial
ovarian cancer (Tokunaga et al., 2008), and colon cancer (Mazzoccoli et al., 2016; Huisman et al., 2016)iScience 13, 284–304, March 29, 2019 299
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Figure 10. CRY-1 and HIF-1a Show an Opposite Role on Cell Proliferation and Migration
(A) Representative HIF-1a western blots in WT MEFs, DCRY1, DHIF-1a, and DCRY1/DHIF-1a MEFs.
(B) Proliferation rate of WT, DCRY1, DHIF-1a, and DCRY1/DHIF-1a cells quantified by dynamic imaging using percentage
of confluence at 3-h time intervals.
(C) Chart of 24- and 36-h time points. Statistics, Student’s t test for paired values: *significant difference, p % 0.01.
(D) Quantification of the colony formation ability of WT, DCRY1, DHIF-1a, and DCRY1/DHIF-1a cells as measured by soft
agar assay. The cells were plated in soft agar and allowed to grow for 2 weeks under hypoxia. Cell growth was measured
using Resazurin staining in a microplate reader with an excitation wavelength of 584 nm and emission at 612 nm. The
OD612 in WT MEFs was set to 100%. Statistics, Student’s t test for paired values: *significant difference, p < 0.05.
(E) Representative images of the wound recovery ofWT,DCRY1,DHIF-1a, andDCRY1/DHIF-1a cells at 0, 12, and 24 h after
introduction of the wound. Scale bar, 300 mm.
(F) Chart of 12- and 24-h time points. Statistics, Student’s t test for paired values: *significant difference, p < 0.01.indicate a reduced CRY1 expression and associated this, as well as a deregulation in Bmal1 or Per2 expres-
sion (Huisman et al., 2016), to be a negative prognostic marker.
Vice versa, HIFs are frequently found to be enriched in the hypoxic areas of solid tumors (Talks et al., 2000;
Zhong et al., 1998). By showing that CRY1 deficiency induces HIF levels (Figures 10 and S6) and accelerates
proliferation and migration, two key aspects relevant to carcinogenesis, and that knocking out HIFs either
by CRISPR/Cas9 or by the use of shRNAs reversed these effects, our study now provides a mechanistic link
between the above-mentioned genetic association studies.
Although these findings underline the connection between CRY1 and HIFs, it appears that other regulators
involved in carcinogenesis can also be regulated by CRY1. For example, several findings from both Per and
Cry knockout mice strongly suggest that their dysfunction cooperates with loss of p53 during carcinogen-
esis (Fu and Kettner, 2013). This is also in agreement with studies showing the complex interconnections
between the individual components of the circadian clock with nucleotide excision repair and DNA dam-
age in mice (Kang and Sancar, 2009; Kang et al., 2009) which affect not only carcinogenesis but also aging.
In summary, the current study presents a mechanistic link by which the lack of circadian control at the CRY1
level can favor the action of HIFs during cellular growth, which underpins that chronic misalignment be-
tween our lifestyle and the rhythm dictated by our endogenous circadian clock is associated with an
increased risk for various diseases including cancer.
Limitations of the Study
In this study we made use of mice andMEFs to investigate the cross talk between HIFs and CRY1. Although
this study provided novel insights into how CRY1 affects the HIF system in MEFs, subsequent studies are
necessary to investigate the implication for cancer cells and cancer treatment. It is likely, however, that
other circadian proteins (such as tCK2) could contribute to the regulation as well. As different regulators
may affect CRY1 expression and activity in different ways, their exact roles and contributions need to be
further studied.
METHODS
All methods can be found in the accompanying Transparent Methods supplemental file.
SUPPLEMENTAL INFORMATION
Supplemental Information can be found online at https://doi.org/10.1016/j.isci.2019.02.027.
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Figure S1 (refers to Fig.2). The circadian oscillation in NIH 3T3 
cells is affected by HIF-2α and DMOG. (A) Representative 
examples of the bioluminescence oscillations in NIH 3T3 cells 
cotransfected with an mBmal1:luciferase reporter construct and 
either empty vector (black line) or HIF-2α (blue line). (B) Graphical 
illustration of the amplitude (y-axis) and period length (x-axis) upon 
overexpression of HIF-2α. Data are mean ±SEM. * p < 0.001 (C) 
Representative examples of the bioluminescence oscillations in NIH 
3T3mPer2:Luc cells treated with DMSO as a mock and 0.5 mM DMOG. 
(D) Graphical illustration of the amplitude (y-axis) and period length 
(x-axis) upon DMOG treatment. Data are mean ±SEM. *p < 0.05.   
     
Figure S2 (refers to Fig.4). 
CRY1 interacts with HIF-2α. 
(A) Coimmunoprecipitation 
assays (IPs) from wild-type 
(WT) MEFs cultured under 
hypoxia in the presence of 
MG-132. Blots from anti-HIF-
2α IPs were probed with the 
CRY1 and HIF-2α antibody. 
The blots shown are 
representative of two 
independent experiments. (B, 
C) Co-immunoprecipitation 
assays with HEK-293 cells, 
expressing HIF-2α with either 
HA-tagged CRY1 or V5-
tagged CRY2. (B) Blots from 
anti-V5 tag IPs were probed 
with HA-tag and V5-tag 
antibody. (C) Blots from anti-
HIF-2α IPs were probed with 
V5-tag antibody (C*) Please 
note that both plasmids are 
V5-tagged. Therefore, the IPs 
were done with HIF-2α Abs 
and probed with anti V5-tag 
Abs thus resulting in 
recognition of both 
overexpressed proteins. (D) 
BiFC analysis. COS-7 cells 
cotransfected with the 
expression vectors for HIF-2α-
YC, CRY1-YN, CRY-YC, 
PER-YN or PER-YC and a 
vector encoding only YN were 
cultured on glass slides for 24 
hrs. The fluorescence 
detection was performed using 
specific filter sets for YFP and 
DAPI.  
Scale bar: 10 µm. (E) 
Quantification of the BiFC 
signal. Cells were transfected 
as in (D) and quantified by flow 
cytometry (cf. Materials and 
Methods). The CMV-YFP 
signal was set to 100%. Data 
are mean ±SEM. * p < 0.05.  
    
  
Figure S3 (refers to Fig.7A,B). CRY1 but not CRY2 modulates hypoxia-
dependent transcription of PAI-1. Wild-type (WT) MEFs, or MEFs deficient for 
CRY1 (ΔCRY1) or CRY2 (ΔCRY2) were cultured under normoxia (16% O2) and 
hypoxia (5% O2). The PAI-1 mRNA and protein levels were measured after 4 hrs 
and 24 hrs by qRT-PCR and Western blot, respectively. (A) Quantitative qRT-PCR 
data. (B) Quantification of the data from Western blots representatively presented 
in (C). The values under normoxia were set to 1. Values represent means ± SEM 
of at least three independent experiments. Statistics, Student’s t-test for paired 
values: *significant difference, p ≤ 0.05. (D, E) CRY1-deficient cells were 
transfected with a plasmid encoding CRY1 or CRY1-Δtail. The PAI-1 protein was 
measured by Western blot with an antibody against PAI-1. The values under 
normoxia were set to 1. Values represent means ± SEM of at least three 
independent experiments.  
Statistics, Student’s t-test for paired values: *significant difference, p ≤ 0.05.  
     
  
Figure S4 (refers to Fig.7C). HIF-2α-dependent transactivation of the HRE-driven promoter Luc construct is 
downregulated by CRY1. Luciferase gene constructs containing 3 HIF-binding HREs (pGL3-HRE) in front of the 
SV40 promoter were cotransfected with expression vectors encoding CRY1, HIF-2α or both in combination. Cells 
were cultured under normoxia (16% O2) and hypoxia (5% O2) for 24 hrs before luciferase assay; In each 
experiment the Luc activity of pGL3-HRE transfected cells at 16% O2 was set to 1. Values are means ± SD of four 
independent culture experiments, each performed in duplicate. Statistics, Student’s t-test for paired values: 
*significant difference, p ≤ 0.01.      
  
Figure S5 (refers to Fig.7D). Deficiency of CRY1 favors binding of HIF-2α to HRE-containing promoters. 
ChIP-qPCR analyses were performed in wild-type or CRY1-deficient MEFs, cultured under hypoxia for 16 hrs; 
DNA fragments were co-precipitated with antibodies against mouse HIF-2α and amplified by qPCR using primers 
specific for the mouse PAI-1, VEGF-A, PGK-1 and GLUT-1 promoters. Chromatin immunoprecipitation without 
antibody or using IgG instead of antibody served as an additional specificity control. Differences in HIF-2α DNA 
binding efficiency in wild-type and ΔCRY1 MEFs were calculated by the fold enrichment method relative to the IgG 
control. Values are means ± SEM of three independent experiments. *significant difference, p ≤ 0.05.  
     
  
Figure S6 (refers to Fig.10). CRY1 and HIFs have 
opposite roles on cell proliferation and migration. 
(A-D) Wild-type (WT) and CRY1-deficient (ΔCRY1) 
MEFs were transduced with retroviral particles 
expressing a scrambled non-coding shRNA (shCtr), a 
shRNA against HIF-1α or shRNA against HIF-2α. (A) 
Soft agar colony formation. Cells were plated onto soft 
agar and allowed to grow under hypoxia for 2 weeks. 
After staining with Resazurin the absorbtion was 
measured at an excitation wavelength of 584 nm and 
emission at 612 nm. The OD of the WT cells were set to 
100%. Values represent means ± SEM of at least three 
independent experiments. (B) Transwell migration 
assay. Cells were seeded into Transwell chambers and 
incubated under hypoxia overnight. After staining with 
crystal violet the absorbtion of migrated cells at 595 nm 
was quantified. The OD of the WT cells was set to 100%. 
Values represent means ± SEM of at least two 
independent experiments. Statistics, Student’s t-test for 
paired values: *significant difference, p ≤ 0.05. (C) 
Representative photographs of a transwell migration 
assay. (D) Representative HIF-1α and HIF-2α Western 
blots in WT and ΔCRY1 MEFs transduced with 
respective HIF shRNA expressing retroviral particles.   
     
  
Figure S7 (refers to Fig.10). Lack of HIF-1α and CRY-1 regulates expression of clock genes. Quantification of 
Cry1, Cry2, Per1, Per1, Bmal1, Clock, and Ndr1d1 mRNA levels in MEFs lacking either Cry1 (ΔCRY1), HIF-1α 
(ΔHIF-1α) or both (ΔCRY1ΔHIF-1α). The respective mRNA levels were assessed by qRT-PCR and the mRNA 
levels in wild type (WT) MEFs were set to 1; the values indicate fold-change WT vs the respective knockout. Data 
are mean ±SD (n=3), * significant difference WT vs. knockout.   
     
Transparent Methods  
All biochemical substances and enzymes used were of analytical grade obtained from commercial suppliers.  
  
Animal experiments and monitoring of circadian behavior   
All animal experiments were performed according to protocols approved by the National Animal Experiment Board 
of Finland following the regulations of the EU Directive 86/609/EEC, the European Convention ETS123 and the 
national legislation of Finland. Inbred C57BL/6N male mice were housed under standard conditions and fed ad 
libitum. For monitoring total physical activity (XT) of 2-month-old C57BL/6N mice under normoxia and hypoxia an 
automated infrared analyzing system for small animals (LabMaster, TSE Systems GmbH, Bad Homburg, 
Germany) was used. Before the real experiment the mice were housed individually for 7 days in training cages 
similar to those used in the actual measurements. Animals were maintained in a cycle of 12 hrs light and 12 hrs 
darkness (LD) or in continuous darkness (DD) in constant ambient temperature with water and food available ad 
libitum. The activity data were recorded continuously (every 10 min) for 2 weeks under normoxic or hypoxic 
conditions (17% O2). All data are presented as a mean ± SEM, p≤0.05. Activity records were plotted as actograms  
(http://www.circadian.org/softwar.html) and the period of locomotor activity was determined by the cosinor and 
chisquare method. One-way Anova with post-hoc Tukey HSD Test, Mann Whitney test as well as Student's t-test 
were used to make statistical comparisons between the different conditions.  
  
Cell Culture 
HeLa, HepG2, COS-7 and HEK-293 cells were cultured in MEM (Sigma-Aldrich); mouse embryonic fibroblasts 
(MEFs) were cultured in DMEM (Sigma-Aldrich); NIH 3T3 and NIH 3T3 cell stably expressing a Per2:Luc construct 
(kindly provided by Hiroki R. Ueda [Isojima et al., 2009]) (were maintained in DMEM-Ham-F10 (1:1, Lonza); All 
cell culture media were supplemented with 10% fetal bovine serum (Biochrom), 1% nonessential amino acids 
(PAA Laboratories) and 0,5% antibiotics. The cells were cultured in a normoxic atmosphere of 16% O2, 79% N2, 
and 5% CO2 [by volume] or a hypoxic atmosphere of 5% O2, 90% N2, 5% CO2 [by volume], or in an InVivo2 400 
hypoxia work station (Ruskinn Technologies). 
  
Plasmids  
For luminescence measurements the pGl4.11-Bmal1:luciferase (Bmal1:Luc) construct (kindly provided by Dr. U. 
Schibler, Geneva) (Brown et al., 2005), the reporter plasmids pGL3-hPAI-806/+19, containing the human PAI-1 
promoter 5’-flanking region from -806 to +19 and the mutant pGL3-hPAI-806HREm (Dimova et al., 2005) as well 
as the pGL3-HRE and pGL3-HREm luciferase reporter plasmids containing 3 repeats of a wild-type HRE or mutant 
HRE, respectively, (Liu et al., 2004) were used as a reporters.   
The expression plasmids encoding full-length HIF-1α with mutations in proline 402, proline 564, and asparagine 
803 as well as full-length HIF-2α were already described (Flügel, Görlach & Kietzmann, 2012). The expression 
plasmids encoding HA-tagged wild-type CRY1 and HA-tagged CRY1 mutants HA-CRY1mutNLSc (with mutations 
in a bi-partite nuclear localization signal domain), HA-CRY1Dtail (deletion of the C-terminal tail), HA-CRY1ΔCC 
(deletion of the coiled-coil (CC) domain), HA-CRY1ΔCCmutNLSc (deletion of the CC domain and mutation in 
NLS), HA-CRY1ΔCCtail (deletion of the CC domain and tail), HA-CRY1ins 487 were already described (Chaves 
et al., 2006). The expression vectors for ARNT in p3XFLAG-Myc-CMV™-24 (Sigma-Aldrich) as well as the 
constructs for BiFC assays were cloned during the course of this study.   
The wild-type human HIF-1α  cDNA cloned into pCMV-Myc (Clontech) (Flugel et al., 2007) was used as a template 
to generate expression constructs for various HIF-1α  mutants by using the OuickChange mutagenesis kit 
(Stratagene) followed by digestion and re-ligation (primer sequences are listed in Table S1). The HIF-1α variants 
are: bHLH (containing HIF-1α amino acids 1-80 encompassing the bHLH domain), bHLH-PAS A (containing HIF1α 
amino acids 1-200 and lacking PAS B, ODD, ID and CAD), bHLH-PASA-PASB (containing HIF-1α amino acids 1-
350 and lacking ODD, ID and CAD), bHLH-PASA-PASB-ODD (containing HIF-1α amino acids 1-603 and lacking 
ID and CAD), bHLH-PASA-PASB-ODD-ID (HIF-1α amino acids 1-786 lacking the CAD), bHLH-ODD-ID-CAD 
(lacking PAS A and PAS B domains) and PAS A-PAS B-ODD-ID-CAD (lacking the bHLH domain). The constructs 
for production of retroviral particles expressing shRNA against Mus musculus HIF-1α (# TG517255), HIF-2α (# 
TF500609) and scrambled negative shRNA (# TR30013) were purchased from OriGene Technologies Inc. 
(Rockville, MD). The CRISPR-Cas9 backbone plasmid, pSpCas9(BB)-2A-GFP (PX458) (Addgene #48138) was a 
generous gift from Dr. Feng Zhang (Ran et al., 2013)  
  
RNA preparation and quantitative real-time PCR  
Isolation of total RNA was performed using the Qiagen RNeasy® Mini Kit (Qiagen, Switzerland) and with a 
GenElute mammalian total RNA miniprep kit (Sigma-Aldrich) following the manufacturer’s instructions. Reverse 
transcription was conducted with 1 µg of total RNA and qScript cDNA Synthesis kit (Quanta Bioscience, GE 
Healthcare). Quantitative real-time PCR was performed in duplicate or triplicate using an iTaq Universal SYBR 
Green Supermix reaction kit (Biorad, Finland) and Applied Biosystems 7500 Real-Time PCR System (Life 
Technologies, Finland). All primer sets (Table S1) were validated for their product and amplification efficiency 
using standard dilution analysis and melting curve analysis. β-Actin, 18S rRNA and Hprt (hypoxanthine-guanine 
phosphoribosyltransferase) were used as internal controls to normalize the variability in expression levels. The 
relative quantification of gene expression was determined using the ΔΔCt method (Schmittgen, Livak, 2008, Livak, 
Schmittgen, 2001).  
  
Transfections and real-time bioluminescence   
HepG2 cells, 4 x 105 per 60-mm dish were transfected essentially as described (Immenschuh et al., 1998). In brief, 
2 µg of the appropriate promoter Firefly luciferase (Luc) constructs were cotransfected in duplicate with 0,5 µg of 
the respective expression vector for HIFs, ARNT or CRY1, or with empty vector in the controls. After 5 hrs the 
medium was changed, and the cells were cultured under normoxia and/or hypoxia as indicated.   
For real-time monitoring of the circadian oscillations in cell cultures, cell medium was buffered with 25 mM HEPES 
containing 0.1 mM luciferin (Sigma-Aldrich) for 2 days prior measurement. After synchronization of intracellular 
clocks by treatment of confluent cultures with 10 µM forskolin, plates were sealed and the bioluminescence was 
recorded for at least 5 days (75 sec measurements at 10 min intervals) with a LumiCycle 32-channel automated 
luminometer (Actimetrics). The data were analysed with the Actimetrics software using the running-average 
method and two sample comparisons were done using a paired Students t-test.  
  
Western blot analysis, co-immunoprecipitations and HIF-1α protein half-life studies  
Western blot analysis was carried out as described (Immenschuh et al., 1998). In brief, media or total cellular 
lysates were collected, and 100 µg of protein was loaded onto a 10% or 7.5% SDS-polyacrylamide gel and, after 
electrophoresis and blotting, probed with a primary monoclonal antibody directed against human HIF-1α  (1:2000, 
Novus, Littleton, USA), myc-tag (1:1000, Cell Signaling, Frankfurt/M, Germany), or with a primary polyclonal 
antibody against HA-tag (1:500, Santa Cruz, Heidelberg, Germany), mouse HIF-1α (1:2000, Novus, Littleton, 
USA), CRY1 (H-84; 1:1000; Santa Cruz Biotechnology), Golgi membrane (1:10000; Biosciences, Goettingen, 
Germany), β-actin (1:10000, Sigma-Aldrich) and α-tubulin (1:10000, Sigma-Aldrich). The enhanced 
chemiluminescence system (ECL; Amersham Biosciences) was used for detection.   
Co-immunoprecipitation experiments were performed either in hypoxic wild-type MEFs or in HEK-293 cells 
transiently transfected with full-length HA-tagged CRY1, V5-tagged CRY2, myc-tagged HIF-1α or V5-tagged HIF-
2α. Twenty hours post-transfection total cellular protein extracts were isolated and 150 µg protein extracts were 
cleared with 2 µg of antibody pre-coupled to protein-G-Sepharose (Amersham, Freiburg, Germany). The samples 
were then subjected to Western blot analyses using anti-HIF-1α, anti-HIF-2α, anti-CRY1, anti-myc-tag, anti-V5tag 
or anti-HA-tag antibodies. HIF-1α half-life studies were performed under hypoxia in wild-type and ΔCRY1 MEFs 
treated with cycloheximide (10 μg/mL; Sigma-Aldrich). After harvesting the cells at the indicated time points, the 
endogenous HIF-1α protein levels were measured by Western blot.  
  
BiFC analyses   
For BiFC assays, pCMV-HA (Clontech) was used as a backbone for generation of the pCMV-YN, pCMV-YC, 
pCMV- HIF-1α-YC, pCMV-CRY1-YN and pCMV-ARNT-YN constructs; their correctness was proven by DNA 
sequencing. In brief, the sequences encoding HIF, ARNT and CRY were fused to sequences encoding YFP 
residues 1–154 (YN) or residues 155–238 (YC). The coding regions were connected by linker sequences encoding 
RSIAT (YN) or RPACKIPNDLKQKVMNH (YC) and were fused to the amino-terminal HA epitope tag in pHA-CMV 
(Clontech).   
COS-7 cells were cultured in 6-well plates on glass slides to about 50% confluence and cotransfected with 
expression vectors pCMV-HIF-1α-YC and either pCMV-CRY1-YN, pCMV-ARNT-YN or pCMV-YN (2,5 µg each). 
The fluorescence was observed 24 h post-transfection using an inverted fluorescence microscope (Carl Zeiss 
AxioVert 200M). YFP fluorescence was captured using an excitation wavelength of 500 nm and an emission 
wavelength of 535 nm. The nuclei of fluorescent cells were stained with 4′,6-diamidino-2-phenylindole 
dihydrochloride (DAPI).   
Quantification of the BiFC Signal was perfomed by flow cytometry. In brief, cells were transfected as above and 
48 hrs post transfection cells were washed with PBS and harvested by trypsin-EDTA. Cells were then pelleted by 
centrifugation at 1000 rpm for 2 min. The cell pellet was resuspended in 1.5 ml of PBS. The BiFC signal was 
quantified using the CyFlow Space flow cytometer equipped with an appropriate filter set for YFP. In each case, 
triplicates of 5000 cells were counted and used to calculate the average BiFC signal intensity in each sample using 
the FloMAX software. The fluorescence for maximal fluorescence in each experiment, against which The BiFC 
signal intensities were normalized against the signal from full-length YFP which was set to 100%.  
  
Chromatin immunoprecipitation   
ChIP analyses were carried out according to the protocol for fast ChIP (Nelson, Denisenko & Bomsztyk, 2006). In 
brief, confluent wild-type and DCRY1 MEFs cultured under normoxia or hypoxia for 16 hrs were crosslinked with 
formaldehyde, lysed, and sonicated to obtain DNA fragments in a size from 250 to 500 bp. Then, chromatin was 
precipitated with a mouse HIF-1α, HIF-2α antibody (Novus, Littleton, USA) or unspecific IgG. DNA from chromatin 
immunopreciptiations was analyzed by quantitative real-time PCR. Differences in the HIF-1α and HIF-2α DNA 
binding efficiency in wild-type and ΔCRY1 MEFs were calculated by the fold enrichment method relative to the IgG 
control using the formula 2-(Ct [IP] - Ct [IgG]).  
  
Generation of HIF-1α knockout MEFs by CRISPR-Cas9-mediated genome editing   
A 20-bp guide sequence targeting the third exon of mouse HIF-1α (HIF-1α-001, ENSMUST00000021530.7) was 
designed online using Zhang’s laboratory web resource (www.genome-engineering.org); a non-targeting, 
scrambled sequence (OriGene) was used as a negative control. gRNA-encoding oligonucleotides (Sigma-Aldrich) 
were cloned into the vector SpCas9(BB)-2A-GFP (PX458, Addgene plasmid ID 48138) using standard procedures 
as described (Ran et al., 2013). The generation of the HIF-1α control and knockout cells via CRISPR-Cas9-
mediated non-homologous end-joining (NHEJ) DNA repair and the screening was performed according to 
described guidelines (Ran et al., 2013). In brief, the wild-type and ΔCry1 MEFs were transiently transfected with 
either the genome editing or the scrambled CRISPR-Cas9 construct and 48 hrs post-transfection cells were 
subjected to single-cell-sorting (BD FACSAria™ III cell sorter). The single-cell clones were expanded and 
screened for frame-shift mutations; shortly, a region spanning the target site was amplified by PCR from genomic 
DNA isolated from clonal cell lines. PCR products were subsequently cloned into pUC19 (Invitrogen). 15-20 
sequences were analyzed per clone by aligning them to the WT HIF-1α sequences using BLAST and Serial Cloner. 
All primer sequences are listed in Table S2.  
  
Live Cell Imaging Assays   
For real-time quantitative live-cell proliferation analysis, 5x103 cells per well were seeded onto 96-well plates. Live 
phase contrast recording of cell confluence was performed in the IncuCyte® ZOOM System (Essen BioScience) 
for 72 h in 3 h intervals. For the scratch wound assays, 4x104 cells per well were seeded onto 96-well Essen 
ImageLock Plates (Essen Bioscience) in the presence of a proliferation inhibitor (mitomycin, 1µg/ml). The following 
day the confluent cell monolayer was wounded with the 96 PTFE pin Wound Maker (Essen Bioscience) and the 
live wound closure was recorded for 45 h in 3 h intervals. In both assays, the confluence analyses were performed 
using the basic IncuCyte software settings.  
  
Colony formation   
Anchorage-independent growth was analyzed in a three-layer soft agar assay as described (Flügel, Görlach & 
Kietzmann, 2012). In brief, the 1x103 cells per well were seeded in triplicates and incubated at 37°C for 14 days 
under normoxia and/or hypoxia before the colonies were visualized with resazurin or crystal violet. Cell growth 
was measured in a Fluroskan Ascent FL type 374 (Thermo Scientific) with an excitation wavelength of 584 nm 
and emission at 612 nm.   
  
Transwell migration assay   
Cell migration assays were conducted in vitro in transwell chambers (Becton Dickinson) as described (Flügel, 
Görlach & Kietzmann, 2012). In brief, serum-starved cells were seeded into the top chamber at a density of 2x104 
cells/well in 500 µl of serum-free DMEM; the bottom chamber was filled with 600 µl DMEM containing 10% FBS. 
After 18 hrs in a humidified hypoxic incubator, cells were fixed and stained with crystal violet. The absorption of 
migrated cells at 595 nm was quantified.   
 
Satistics 
Statistical analyses were performed with GraphPad Prism version 5 (GraphPad Software). Parameters and 
experimental details can be found in the figure legends. The Student’s t test with a p-value of at least p ≤ 0.05 was 
considered statistically significant. 
    
Table S1. (refers to Fig.6) Primers used for generation of HIF-1α deletion constructs. The wild-type human 
HIF-1α cDNA cloned into pCMV-Myc vector (Clontech) was used as a template for generating expression 
constructs for different HIF-1α mutants. The OuickChange mutagenesis kit (Stratagene) was used to introduce 
restriction enzyme sites and/or stop codon (underlined) and was followed by digestion and re-ligation. The 
antisense primers contained the reverse complementary sequence of the sense primer. The correctness of all 
designed deletion mutants was proven by DNA sequencing.  
  
Construct  (bp)  Sequence (5’- 3’) of the sense mutagenesis primers  Deleted domain  digest  
bHLH  
243  ctggatgctggtgattagggtaccgaagatgacatgaaagcacag  
PAS A,  
PAS B, 
ODD,  
ID, CAD  
Kpn I  
bHLH-PAS A  
528  gcgaagcttttttctctgaatgtagggtaccctaactagccg  
PAS B, 
ODD,  
ID, CAD  
Kpn I  
bHLH-PAS 
APAS B  1215  
cctgatgctttaacttagctggtaccagccgctggagacac  ODD, 
ID, CAD  Kpn I  
bHLH-PAS A- 
PAS B- ODD  1830  cagtattccagtagactcaggtaccagaacctactgctaatgccacc  ID, CAD  Kpn I  
bHLH-PAS A- 
PAS B- ODD- 
ID  
2379  ctgctggggcaatcataggatgaaagtggggtaccacagctgacc  CAD  Kpn I  
bHLH-ODD-
IDCAD  1800  
gctatttgcgtgtgaggaagcttctggatgctggtg  
ggacaagtcaccacaggaaagcttaggatgcttgccaaaagagg  
PAS A, 
PAS B,  
Hind  
III  
PAS A-PAS B- 
ODD-ID-CAD  2238  ggtgatttggatattgaagaggccatggaggcccagatgaa  bHLH  Sfi I  
  
    
Table 2S. (refers to Fig.4, 7, 10) Primer sequences  
Gene/ 
Construct  Forward (5’-3’)  Reverse (5’-3’)  
 qPCR primers   
Pai-1  GTGAATGCCCTCTACTTCAGTG  GCTGCCATCAGACTTGTGGAA  
Hif1α  GGGGAGGACGATGAACATCAA  GGGTGGTTTCTTGTACCCACA  
Hif2α  TCCTTCGGACACATAAGCTCC  GACAGAAAGATCATGTCACCGT  
ActB  GTTGTCGACGACGAGCG  GCACAGAGCCTCGCCTT  
18S rRNA  GTAACCCGTTGAACCCCATT  CCATCCAATCGGTAGTAGCG  
Hprt  CGAAGTGTTGGATACAGGCC  GGCAACATCAACAGGACTCC  
Cited2  CGCCAGGTTTAACAACTCCCA  TGCTGGTTTGTCCCGTTCAT  
Glut1  CTCTGTCGGCCTCTTTGTTAAT  CCAGTTTGGAGAAGCCCATAAG  
Cry1  CACTGGTTCCGAAAGGGACTC  CTGAAGCAAAAATCGCCACCT  
Cry2  CACTGGTTCCGCAAAGGACTA  CCACGGGTCGAGGATGTAGA  
Per1  TGAAGCAAGACCGGGAGAG  CACACACGCCGTCACATCA  
Per2  GAAAGCTGTCACCACCATAGAA  AACTCGCACTTCCTTTTCAGG  
Bmal1  TGACCCTCATGGAAGGTTAGAA  GGACATTGCATTGCATGTTGG  
Clock  CTTCCTGGTAACGCGAGAAAG  GTCGAATCTCACTAGCATCTGAC  
Nr1d1  ATGTCCCGAGAGCTACATGAC  CCTGCTCCTGAACATCGAACT  
 BiFC    
pCMV-YC  CGAATTCAAGCTTCTCGAGACGCGTATGGGTAC  CCATACGCGTCTCGAGAAGCTTGAATTCGGGC C  
pCMV-YN  AATTCGGGCCCACGCGTGGTACCT  TAGAGGTACCACGCGTGGGCCCG  
pCMV-
CRY1YC  GAATTCAAGCATGGGGGTGAACGCCGTGC  
GGCCCTCTAGAGTTACTGCTCTGCC  
pCMV-HIF-1α -
YC  
CTGAAGCTTGCGGCCGCACGTCCGGCGTGCAAAA 
TC  
CATGCAAGCTTCGCGGGTACAATTCCGCAGCT 
TTTAG  
 ChIP primers    
Pai-1  GTCTAGACGACCGACCAGCCAAA  GAAATGTCTGGGCTGCCCGC  
Pgk-1  GGCATTCTGCACGCTTCAA  GAAGAGGAGAACAGCGCGG  
Glut-1  ATTTCTAAGGCCCTGGGTCC  CCTGCCTGATGCGTGTCA  
Vegf-A  CAGTTGTCTCTCCTTCAGGGCT  GAAACCCACGTATGCACTGTGTA  
ActB   GTGAGTGAGCGACGCGGAGCCAA  CTTACCTGGTGGCGGGTGTGGA  
 CRISPR-Cas9    
Hif1  
(guide)  GCTAACAGATGACGGCGACA    
Hif1a  
(genotyping, 
sequencing)  
CACCCTTGGTGATTTGCTTGT  CCTCATGGTCACATGGATGAGT  
Hif1a    GATATGAATTCACCCTTGGTGATTTGCTTGT  CGATAAGCTTCCTCATGGTCACATGGATGAGT  
 (pUC19 
cloning, 
sequencing)  
  
Rom1   
(off-target)  GGTGGGAAGGGGAAAGATGG  ACAGTGATTTCTGTCCACAAACTT  
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